enzyme; (2) it never substitutes for ABA as an activator of the ABA signal transduction pathway; and (3) it is easily prepared from a synthetic intermediate which can be modified to improve the properties of the final product. In this study, we designed (±)-(1'S*,2'S*)-The lead compound 2 was synthesized from 2,2,6-trimethylcyclohexanone as shown in Scheme 1a.
The reaction of 2,2,6-trimethylcyclohexanone with 2-propynyl tertbutyldimethylsilyl (TBS) ether and n-butyllithium (n-BuLi) gave the ether 6, whose relative configuration is (1'S*,2'S*), and its diastereomer, whose relative configuration is (1'S*,2'R*), in a ratio of 12:1. The 1'-hydroxyl group of 6 was in the equatorial orientation, which was most likely formed by the preferential axial attack on the 2,2,6-trimethylcyclohexanone by the acetylide anion.
10,11
Reduction with sodium bis(methoxyethoxy)aluminum hydride (SMEAH), de-protection with AcOH and H 2 O in tetrahydrofuran (THF), and oxidation with pyridinium dichromate (PDC) yielded the aldehyde 7.
The HornerEmmons reaction of 7 with ethyl di-o-tolylphosphonoacetate yielded the ethyl ester 8; the ratio of 2Z/2E isomers was 4:1. Basic hydrolysis of 8 and separation of the isomers by silica gel column chromatography with 8-15% acetone in CH 2 Cl 2 containing 0.5% AcOH, and by octadecylsilyl (ODS) column chromatography using Sep-Pak Plus C18 cartridges (Waters) with 75% MeOH in H 2 O containing 0.1% AcOH, produced compound 2 as a colorless oil (29% yield from 2,2,6-trimethylcyclohexanone).
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In difference NOE and 2D NOE (NOESY) experiments in a CDCl 3 solution, the 5-proton of 2 exhibited NOEs to the 3'-, 5'-, 7'-and 9'-protons, and the 8'-protons showed NOE to the 2'-proton ( Figure 3 ). The result suggests that the ring conformation of 2 is a chair with an axial side-chain and that the relative configuration of 2 is (1'S*,2'S*); that is, the 2'-methyl group is cis to the side-chain.
The 8'-difluorinated derivative, (±)-(1'S*,2'S*,6'S*)-6-nor-2',3'-dihydro-4'-deoxo-8',8'-difluoro-ABA (4), was synthesized from compound 9 (prepared as reported previously)almost the same method used for 2 (Scheme 1b), and was identified by spectral data.
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The conformation of 4 is a chair with an axial side-chain and the relative configuration of 4 is (1'S*,2'S*,6'S*), which was confirmed by difference NOE and NOESY experiments (Figure 3 ).
Biological activity
The biological activities of 2 and 4 were evaluated in two bioassays.
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In the rice seedling elongation assay, the IC 50 values of both compounds were more than 300 μM, whereas that of (±)-ABA was 2 μM.
On the other hand, the IC 50 value of 4 in the lettuce seed germination assay was 150 μM, whereas that of (±)-ABA was 12 μM. The IC 50 value of 2 in the same assay was more than 300 μM. These results suggest that compounds 2 and 4 are much poorer ligands than ABA for the ABA receptors.
Microsomal assay
To examine whether compounds 2 and 4 can inhibit the ABA 8'-hydroxylase reaction, we carried out in vitro ABA 8'-hydroxylase assays using recombinant CYP707A3.
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The inhibition constants (K I ) and inhibitor types were determined from a Dixon plot. As shown in Table 1 , compounds 2 and 4 inhibited the CYP707A3 reaction (IC 50 = 0.91 and 0.63 μM, respectively). The kinetic analysis revealed that both compounds acted as competitive inhibitors of the enzyme; the K I value was 0.40 μM for 2 and 0.41 μM for 4.
These values are lower than the K M value for ABA (1.3 μM), suggesting that compounds 2 and 4 are effective inhibitors of CYP707A3.
Compound 2 functioned as an enzyme substrate, although the yield of enzyme products from 2 relative to those from ABA was estimated to be 17% (Table 1 ). In contrast, compound 4 resisted hydroxylation at C-8', which is consistent with the design concept.
Compound 2 is an effective inhibitor of ABA 8'-hydroxylase, and rarely activates the ABA signal transduction pathway. Additionally, this compound is easily prepared and column, and NaOH, MeOH, RT, 13.5 h, 32%. Compound 9 was prepared from 2,6-dimethylcyclohexanone as reported previously. 
